Dr. Carolina Gandara, Head of Retina Assay Development at Newcells Biotech, leads internal and external projects within the retina platform, overseeing a team of scientists focused on creating ...
Adherent cell assays have lagged behind in automation, slowing drug discovery. Semarion’s SemaCyte® microcarrier platform streamlines these workflows by making adherent cells assay-ready, improving ...
This article is sponsored by BellBrook Labs and INTEGRA BIOSCIENCES. High-throughput screening emerged in the late 1980s, driven by advances in chemistry and genomics. With recent breakthroughs in ...
Boost ROI with automation, multiplexing, AI analytics, validated 3D models, and CRO partnerships that reduce variability and scale screeningDublin, Oct. 19, 2026 (GLOBE NEWSWIRE) -- "Cell-based Assay ...
(MENAFN- GlobeNewsWire - Nasdaq) Demand for ethical, faster safety testing is driving in-vitro assays, with opportunities in 3D cultures, organ-on-chip, AI, high-throughput screening and emerging ...
In the ever-evolving landscape of biomedical research, the need for reliable, consistent, and ready-to-use cell models has never been more critical. ATCC, a leading provider of biological materials, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results